Riskpilot← Back to searchSign inGet full accessHendrix Genetics Swine Denmark A/S
A/SActiveCVR 26039282Nordager 2Wholesale of live animals · NACE 4623Est. 200138 employeeswww.hendrix-genetics.com
Revenue 2024
DKK 2M
-94% vs 2023
EBITDA margin
-1319.7%
-743% vs 2023
Equity ratio
-35.1%
Financial strength
Net profit 2024
DKK -29,1M
-756% vs 2023
| Revenue | DKK 2M | -94% |
| EBITDA | DKK -26M | -743% |
| Net profit | DKK -29,1M | -756% |
| Total assets | DKK 68,5M | -21% |
| Equity | DKK -24,1M | -581% |
| Employees | 38 | — |
Legal name
Hendrix Genetics Swine Denmark A/S
CVR number
26039282
Legal form
Aktieselskab
NACE code
4623 · Wholesale of live animals
Founded
25. april 2001
Share capital
DKK 2.500.000
Employees
38 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør, af et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med opformering af svin, svineavl og dermed beslægtet virksomhed og efter bestyrelsens bestemmelse anden virksomhed, som står i naturlig forbindelse hermed.
Address
Nordager 2
Phone
+4570260616
Email
mail.dk@hendrix-genetics.com
Website
www.hendrix-genetics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 17.189 | 41.961 | 15.561 | 30.857 | 1.972 |
| Staff expenses | -9.339 | -30.192 | -26.963 | -26.008 | -28.001 |
| EBITDA | 7.850 | 9.411 | -11.813 | 4.050 | -26.029 |
| Depreciation & amort. | -1.834 | -8.419 | -8.718 | -7.825 | -6.733 |
| EBIT | 6.017 | 992 | -20.531 | -3.775 | -32.762 |
| Net financials | -321 | -1.136 | -6.151 | -843 | -4.031 |
| Profit before tax | 5.690 | -145 | -26.702 | -4.618 | -36.793 |
| Tax | 1.480 | 261 | -4.694 | -1.223 | -7.725 |
| Net profit | 4.210 | -406 | -22.008 | -3.395 | -29.068 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 127.953 | 104.194 | 100.282 | 87.186 | 68.548 |
| Equity | 18.394 | 17.988 | 6.020 | 5.007 | -24.083 |
| Long-term debt | 17.773 | 24.252 | 31.272 | 30.687 | 22.965 |
| Short-term debt | 89.160 | 58.868 | 62.990 | 51.493 | 69.087 |
| Total debt | 106.934 | 83.121 | 94.262 | 82.180 | 92.051 |
EBITDA margin
-1319.7%
This company
15.8%
Market median
-8453% vs market
20202024
Equity ratio
-35.1%
This company
38.2%
Market median
-192% vs market
20202024
Return on equity
-2906831100.0%
This company
18.4%
Market median
-15797995209% vs market
20202024
Net profit margin
-1473.8%
This company
8.1%
Market median
-18295% vs market
20202024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20202024
Debt / equity
3.85×
This company
0.62×
Market median
-521% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-10-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
JL Founder | Founder | 2001 |
KL Founder | Founder | 2001 |
NS Founder | Founder | 2001 |
MW Management | Management | 2026 |
EG Founder | Founder | 2001 |
JS Founder | Founder | 2001 |
| Former (1) | ||
Jv Chief Executive Officer | Chief Executive Officer | 2025 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2026 | |
| Deputy Chairman | 2026 | |
| Former (4) | ||
| Deputy Chairman | 2025 – 2025 | |
| Chairman | 2001 – 2007 | |
| Chairman | 2025 – 2026 | |
| Chairman | 2007 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2024 | |
| Individual | 20–24.99% | 20% | 2013 | |
| Company | 20–24.99% | 20–24.99% | 2013 | |
| Company | 20–24.99% | 20–24.99% | 2019 | |
| Company | 20–24.99% | 20–24.99% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Danish Genetics Holding ApS
Hendrix Genetics Swine Denmark A/S Board members of Hendrix Genetics Swine Denmark A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Lembke-Jensen | Founder | 0 companies |
| Jeroen van de Camp | Chief Executive Officer | 0 companies |
| Keld Lembke-Jensen | Founder | 0 companies |
| Niels Skjødt Vinderslev | Founder | 0 companies |
| Mikael Wædeled Sigvardsen | Management | 0 companies |
| Esper Goul Jensen | Founder | 0 companies |
| Joachim-Temme Struck | Founder | 0 companies |
| Niels Henrik Reventlow | Deputy Chairman | 0 companies |
| Steen Agerbo Bødtker | Chairman | 0 companies |
| Mads Hans Kring | Deputy Chairman | 0 companies |
| Peder Agger | Chairman | 0 companies |
| Rafael Jacobus Henri Gerard Beeren | Chairman | 0 companies |
| Joan Vollertsen | Chairman | 0 companies |